Stay updated with breaking news from Kitov Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Musculoskeletal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's...
/PRNewswire/ -- The "Global Musculoskeletal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's...
Scopus BioPharma soars on FDA approval At one stage in yesterday's session, Scopus Biopharma's share price was up 100%. It closed up nearly 80%. Drug company Scopus BioPharma Inc. (Nasdaq: SCPS), has reported that the US Food and Drug Administration (FDA) has approved the start of a clinical trial for the company's RNA cancer therapy (CpG-STAT3siRNA), developed in cooperation with the City of Hope hospital in California. A Phase 1 clinical trial for B-cell non-Hodgkin lymphoma will be initiated at City of Hope. At one stage in yesterday's session, Scopus Biopharma's share price was up 100%. I...
Penny Stocks To Buy According To Analysts Whether you love penny stocks or hate them, you canât argue with the fact that big money can be made. By definition, the term itself references stocks to buy for less than $5. So even the slightest 50 cent move from the highest-priced penny stock is a near-market-beating gain. For the most part, newer retail traders actively learn how to day trade and start by focusing on cheap stocks to watch. Since it doesnât take a whole lot of capital to buy penny stocks, theyâve become somewhat of a âgo-toâ for mom-and-pop investors. Thi...
Share: New Name Reflects Company's Evolution to Advancing First-in-Class Oncology Therapies TEL AVIV, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the "Company") (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that it has changed its corporate name from Kitov Pharma Ltd. to Purple Biotech Ltd. The name change will be effective for trading purposes on the Tel Aviv Stock Exchange (TASE) and the NASDAQ Capital Market (NASDAQ) as of market open on December 22, 2020. At that t...